Final Program

396 WEDNESDAY • MAY 18
1:30 The Biology of Acute Exacerbations of COPD
P.J. Barnes, MD, DSc, London, United Kingdom
1:45 The Physiology of Acute Exacerbations of COPD
B.R. Celli, MD, Boston, MA
2:00 Role of the Eosinophil in COPD Exacerbations
C.E. Brightling, BSc, MBBS, PhD, Leicester, United Kingdom
2:15 Kinases and PDE-4 Inhibitors and COPD Exacerbations
F.J. Martinez, MD, New York, NY
2:30 Antioxidant Therapy to Prevent COPD Exacerbations
R.A. Wise, MD, Baltimore, MD
2:45 Potential Role of Anti-Fibrotic Therapy in COPD
G.J. Criner, MD, Philadelphia, PA
3:00 Stimulating Lung Repair Following Acute Exacerbations
S.I. Rennard, MD, Melbourn, United Kingdom
3:15 Targeting the Neutrophil in COPD Exacerbations
H. Magnussen, MD, PhD, Grosshansdorf, Germany
This session and the International Conference are supported by an educational grant from
AstraZeneca LP.
All CME sessions have been planned and implemented in accordance with the Essential
Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME)
and are free of the control of commercial interests.
D84
CLINICAL
CRITICAL CARE TRACK
CME Credits Available: 2.0
STAY AWAY FROM THE ICU: IS PREVENTING ICU
ADMISSION GOOD FOR PATIENTS?
Assembly on Critical Care
1:30 p.m. - 3:30 p.m. MOSCONE CENTER
Room 3000/3002/3004 (West Building, Level 3)
Target Audience
Critical care and emergency medicine professionals; anesthesia clinicians,
including physicians, nurses, and advanced practice providers.
Objectives
At the conclusion of this session, the participant will be able to:
• learn new data on how to identify patients at risk for clinical deterioration;
• better discuss the risks and benefits of ICU admission with patients and
their families;
• better identify patients that will not benefit from ICU admission.
ICU beds and the nurses and physicians that staff them remain a scarce and
costly resource. In addition, admission to an ICU is associated with both
increased intensity of therapy, but also potential increased risks of treatment.
One way to deal with the limitations of bed space as well as the increased risk
of ICU care is to attempt to identify and treat patients at risk for critical illness
earlier in their illness. This session will review available data on identification of
and treatment for patients on the wards and in the prehospital phase, and
whether this will prevent need for ICU admission
Chairing: J.E. Sevransky, MD, MHS, Atlanta, GA
C.R. Cooke, MD, MSc, Ann Arbor, MI
K.S. Mathews, MD, MPH, New York, NY
1:30 Risks and Benefits of ICU Admission
C.R. Cooke, MD, MSc, Ann Arbor, MI
1:50 Can Patients with Severe Sepsis Be Safely Treated on the
Wards?
M.E. Mikkelsen, MD, Philadelphia, PA
2:10 Prehosptial Identification of Severe Sepsis Patients
C. Polito, MD, MSc, Atlanta, GA
2:30 Early Warning Systems to Predict Clinical Deterioration: Do
They Work?
M.M. Churpek, MD, MPH, PhD, Chicago, IL
2:50 Should Palliative Care Consultation Be Used to Prevent ICU
Admissions?
N. Khandelwal, MD, Seattle, WA
3:10 Prevention of Lung Injury
E. Festic, MD MS, Jacksonville, FL
D85
BASIC • BEHAVIORAL • CLINICAL • TRANSLATIONAL
SCIENTIFIC SYMPOSIUM
CME Credits Available: 2.0
EARLY LIFE ORIGINS OF CHRONIC DISEASE
Assemblies on Pediatrics; Clinical Problems; Environmental,
Occupational and Population Health; Pulmonary Rehabilitation;
International Health Committee
1:30 p.m. - 3:30 p.m. MOSCONE CENTER
Room 2016/2018 (West Building, Level 2)
Target Audience
Providers of lung health; trainees; fellows; junior faculty; research scientists;
clinical academics.
Objectives
At the conclusion of this session, the participant will be able to:
• learn new findings about early life origins of chronic disease;
• gain and apply new knowledge gained to thinking about disease causation;
• understand how early life exposures can increase life long disease risk.
Globally chronic disease is increasing in both developed and developing
countries. Evidence is increasing that most chronic disease has it origin in early
life, that is during the peri-conceptual period, during fetal development and in
early postnatal life. This session will highlight current thinking in how early life
exposures result in chronic disease in later life.
Chairing: M. Rosenfeld, MD, MPH, Seattle, WA
J.C. Celedon, MD, DrPH, Pittsburgh, PA
1:30 Developmental Origins of Health and Disease: The DOHAD
Studies
M. Hanson, MA, DPhil, Southampton, United Kingdom
1:55 Impact of Prenatal and Early Life Exposures on Development
T. Bastain, PhD, MPH, Los Angeles, CA
ATS 2016 • San Francisco